| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $114.9M | +1.9% |
| SG&A Expense | $49.7M | -2.0% |
| Operating Income | -$164.5M | -0.7% |
| Interest Expense | $30.8M | +35.9% |
| Income Tax | $0 | — |
| Net Income | -$117.8M | -348.5% |
| EPS (Basic) | -$1.88 | -347.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.1M | -35.5% |
| Short-term Investments | $164.7M | -10.4% |
| Accounts Receivable | $8.1M | -96.2% |
| Current Assets | $217.9M | -50.8% |
| Total Assets | $378.3M | -36.0% |
| Current Liabilities | $53.3M | -60.9% |
| Long-term Debt | $213.2M | -32.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $74.7M | +186.4% |
| Capital Expenditures | $426K | +277.0% |
| Investing Cash Flow | $27.5M | +121.5% |
| Financing Cash Flow | -$106.1M | -185.4% |
| Free Cash Flow | $74.3M | +185.8% |
| Stockholders' Equity |
| -$25.0M |
| -129.2% |